Development of drugs in public-private partnership (PPP) environments
1. Development of drugs in public-private partnership (PPP) environments Marija Mavar Haramija / Nathaniel Stanley / Pascal Maugeri April 2011 MSc Bioinfo - Computer Assisted Drug Discovery
20. New Drugs market entry by disorder and primary indication Source: Christopher P. Adams and Van V. Brantner. Estimating The Cost Of New Drug Development: Is It Really $802 Million? Health Affairs, 25, no.2 (2006):420-428
21. The example of Malaria WHO Malaria Report 2008 Estimated incidence of malaria per 1000 population, 2006
22. Grants 4 Targets Distribution of applications received National distribution of applications received, (RoW, Rest of the World)
Notes de l'éditeur
PARASITE
PM= performance management
TDR - 2 main goals: Research and development into new and improved approaches on diseases of poverty. Empowering and building research capacity in the countries where the diseases are prevalent. TDR - 1975 MMV - 1999 GATB - 2000 DNDi - 2003 IOWH - 2001 all are working on several (10) projects, developing new drugs that will be affordable and accessible
![Agenda 15-min slides + 10-min debate ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)